chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient (pt) of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 14-DEC-2013, pt was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, and route of administration were not specified), as prescribed and/or administered by a healthcare provider at the clinic for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, pt was treated by a healthcare professional for shingles. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the event was considered to be not recovered. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Patient reported to his home health nurse that he couldn't walk for a couple of days after receiving the vaccine.  He feels it was due to the COVID shot, not the flu vaccine he received on the same day as he has had many flu vaccines in the past.  The feeling of not being able to walk resolved and he is doing fine now.
Patient developed rash to face, scalp, chest, and bilateral arms about 12-13 days after receiving vaccination.  Rash is itchy.  Patient presented with scattered papules and vesicles on erythematous base.
palpitation; a rash all over her body including arms to the sole of her feet; short of breath; injection site itching; injection site swelling; injection site redness; A spontaneous report (United States) was received from a nurse concerning a female patient of 44 year old, who received Moderna's COVID-19 vaccine(mRNA-1273) and experienced Injection site redness/vaccination site erythema, injection site swelling/vaccination site swelling, injection site itching/vaccination site pruritus, short of breath/dyspnoea, palpitation and rash all over body.  The patient's medical history was not provided. No relevant Concomitant medications were reported.  On 29 Dec 2020, prior to the onset of events, the patient received their first of two planned dose of mRNA-1273 vaccine via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, patient experienced a rash all over the body including arms to the sole of feet, patient was short of breath and had palpitation. On 05 Jan 2021, seven days after vaccination, patient experienced Injection site redness, injection site swelling and injection site itching. Treatment information for the event included cream and Benadryl.  Action taken with the mRNA-1273 in response to the event was not reported.  The outcome of the event Injection site redness, injection site swelling, injection site itching, short of breath, palpitation and rash all over body was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient reported tightness in his chest and difficulty breathing. Patient was instructed to begin taking breaths in through his nose and out through his mouth and 911 was called. Patient never lost consciousness but was unable to speak due to difficulty breathing. Talked to patient to reassure. Asked questions of the female with the patient to gather pertinent information to give to the EMS. Patient's breathing began to slow after 1 to 2 minutes. EMS arrived on the scene. Patient was breathing more normally and able to talk. Oxygen saturation was 99. Patient's BP and HR were slightly elevated. Patient's only complaint at that point was weakness. Patient's breath sounds were clear. EMS offered transport to the hospital and patient declined.
Patient reports soreness in the arm, headache onset, sneezing, runny nose and itchy in  throat, itchiness in eyes and on ears. Patient states she has allergies and also asthma, all itchiness is related to her allergies.
Within two weeks of hep b vaccine pt developed pain, weakness, and then paralysis in her left arm.
C/o pain and swelling, no redness notes no swelling noted, patient stated at 7 days out arm still sore. doctor gave steroid shot.
When administering the TDAP vaccine, the vaccine fluid shot out at nurse. Device malfunction - that is, the device did not do what it was supposed to do.
Immediate fever (101.4, rectal), muscle soreness, and headache. Lasted 1.75 days with temperature rising to 102.4.  Temperature returned to normal by 2 days after inocculation. 8-inch long x 3-inch wide slightly swollen tender area developed just below area of needle insert; still present at time of this report (3 days since vaccination) but decreasing in tenderness.
1 1/2 hrs p/vax started crying inconsolably for 2 hrs in spite of taking APAp a/hand; slept alittle then crying very hard off and on for 36 hrs total; fever 102; mom sponged pt fever down to 99 R next AM;
3/26/2021 (day of vaccine) 8:30pm ~6.5 hours after injection.  Mild pain at injection site. 3/27/2021 Woke with moderate headache across forehead, nausea upon standing,  difficulty regulating body temperature, injection site pain upon any pressure, injection site swelling, lack of appetite, and fatigue.  Lasted entire day. 3/28/2021 Moderate headache continues.  Nausea remains.  Still having difficulty regulating body temp.  Injection site discomfort.  Lack of appetite.  Fatigue.  Mild lightheadedness in the evening.  3/29/2021 Finally feeling much better.  Headache subsided withing 4 hours, energy levels and appetite are returning.  Injection site is still tender.
At 6:30am on 03/10/2021 after the shot, I had Bell's palsy on the left side of my face, throughout the day I noticed my lip and face was droopy. I was concerned I was having a stroke and went to the emergency room at 1:30pm. I was released the same day with steroids and received a CT scan. On 03/16/201, I went to see my primary care doctor due to symptoms remaining. The doctor did not prescribe any medication and stated to give it time. I went back to the doctor 08/31/21 due to symptoms being persistent and prescribed more steroids and doctor stated to give it some time.
Chills, headache, tired, fever, muscle aches all over.  These sysptoms lasted about 15 hours
Right thigh area of redness and high local temperature and swelling about 6 cm x 6 cm.
she was also nonresponsive to pneumococcal vaccine; This information has been received from the authors in a published literature marketed article, entitled as stated below, referring to a 61-year-old female patient at reporting time. Her current conditions included the diagnosis of having common variable immunodeficiency (CVID). The authors did not provide further information on the patient's historical conditions, drugs, or vaccines, illnesses at vaccination, and concomitant medications of vaccines.    On an unspecified date, the patient was vaccinated with pneumococcal vaccine (manufacturer unknown) for prophylaxis to which she was nonresponsive (therapy non-responder) (age at vaccination, formulation, concentration, dose number, dose, route and anatomical vaccination location, lot number, and expiration date were not provided).   The event therapy non-responder has been considered related to the pneumococcal vaccine (manufacturer unknown).     A copy of the published article is attached as further documentation of the patient's experience.
PATIENT REPORTS HAVING HEADACHE AND FEVER ONSET 4/9/21; APPROXIMATELY 48 HOURS AFTER VACCINE. HE TOOK APAP FOR SYMPTOMATIC RELIEF. HE BEGIN FEELING BILATERAL KNEE PAIN AND PROGRESSED TO DIFFICULTY WALKING 4/10/21 - WENT TO URGENT CARE DUE TO DIFFICULTY WALKING/BILATERAL KNEE PAIN. 4/11/21 - WENT TO MEDICAL CENTER AND IS CURRENTLY BEING TREATED FOR "TWO SWOLLEN KNEES" -- LEFT KNEE WAS DRAINED OF FLUID.  4/10/21 - WENT TO URGENT CARE DUE TO DIFFICULTY WALKING/BILATERAL KNEE PAIN. 4/11/21 - WENT TO MEDICAL CENTER AND IS CURRENTLY BEING TREATED FOR "TWO SWOLLEN KNEES" -- LEFT KNEE WAS DRAINED OF FLUID.
A physician reported the occurrence of decreased appetite in a neonate of unspecified gender who was vaccinated with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not specified. On an unspecified date, the subject received his first injection of Engerix B. Two to three hours later, the infant did not want to eat. The infant was admitted to the hospital where he was given unspecified tests, including a spinal work up. All of the unspecified tests were reportedly negative, and the symptoms resolved in approximately 24 hours.
One week after shot developed burning pain in arm and shoulder. The pain lasted two weeks then went away. After the pain subsided weakness in the muscles of the shoulder and arm developed.
devel erythema nodosum p/vax;had rash for 6 days;
First Moderna dose 12/28/2020.  Reaction #1: 01/13/2021; 6 cm patch of dry, erythematous, red, scaly, itchy on right knee; subsequently diagnosed as eczema.  Second Moderna dose   1/26/21.  Reaction: Third/fourth week March; second patch developed 6 x 8 cm right knee. Second week of April: Third patch developed right lower leg 10 x 16 cm. Several smaller patches developed in the right thigh and distal left lower leg.  Reaction #2: End of March: Generalized rash with numerous small red, intensely itchy spots over chest and back. Eventually diagnosed by biopsy as Grover's disease in May 2021. Treatment: 4/6/2021 steroid dose pack; improved and recurred. 5/20/2021: Dermatology evaluation; biopsy-proven Grover's disease. Treatment: Triamcinolone cream; improved with treatment  August 2021; all lesions improved with treatment. No lesions completely healed.  Follow-up dermatology, 8/13/2021. Patchy lesions diagnosed as eczema. Continued follow-up treatment Grover's disease.
Rash started on legs,(inner thighs)gradually got worse and spread to upper arm, down rest of legs to bottom of feet and both sides and chest. Was given benadryl and was seen by Dr on 10/23/2009 and was diagnosed with hives and was told to continue benadryl, give zyrtec, and singular.
Chest pain, Shortness of breath, palpitation. This symptoms started around 12/08/2022 Multiple premature ventricular beats on EKG, every third beat was a premature ventricular beat, about 30-35/min. 2D Echo Mild TR Exercise Stress Test: ST Elevation in anterolateral leads, about 2 mm and upsloping I was traveling when symptoms started, did those tests while traveling on 12/10/2021.  Premature beats, mild dull chest pain, palpitation, exertional shortness of breath are persistent.  I have appointment with cardiologist on 01/12/2022.
Patient had first dose on 1/27/21. This second dose was given before the recommended 28 days on 2/19/21. A third dose was given on 2/24/21 without knowledge that the second dose had been given.
Patient states after visit on 08/09/2002, within 3-9 hours after vaccine, had Strept Throat, runny (clear) nose, fatigue, and body aches for 48-72 hours. Symptoms resolved. None today (08/12/2002)
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 11-MAY-2016 the patient was vaccinated with an improperly stored dose of GARDASIL (lot # L040460, expiration date 27-MAY-2017, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 80 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
1st shot: I developed inflammation in right side of my body after having shot in my right arm. My right breast became enlarged and painful with nods in it. As of today 9/22/21 it is still lumpy and painful. I am very uncomfortable with having one breast larger than the other, and it is still painful.   2nd shot: I developed tinnitus in right ear about a week or week and a half following vaccine. The tinnitus was extremely loud and I missed work due to the distress and inability to hear. After another week it occurred sometimes in left ear as well.   Once I could get an appointment to see an ENT doctor (4/19), I was then  diagnosed as having a reaction to the Pfizer shot. I was then tested at Audiology and told I had "sudden onset hearing loss" in the 4000-6000 Hz frequency in my right ear as well as the tinnitus. ENT doctor told me this was a reaction to the Pfizer vaccine I had just taken.  As of today 9/22/21 I still have tinnitus in both ears though it is not as loud as initially.
Vaccine given outside of age parameter.  The mother made an appointment stating it is for her adult autistic child.  When the nurse came to give the vaccine, the mother said again this for her adult autistic child.  The mother signed the consent and answered the pre-vaccination health checklist.  The nurse reviewed the two forms and administered the vaccine.  When the nurse went to document the vaccine, it was discovered the patient was 17.  Upon review, this facility is placing age and date of birth on the consent and checklist.
The client had hives after an injection of hep A and Hep B.  He was taken to the local hospital and discharged with and order for benadryl.
Case previously recorded as MA2009-4337. Initial case report received from a consumer via agency on 17 NOV 2009. An adult female patient was vaccinated i.m. for the first time with S-OIV FLUVIRIN on 17 NOV 2009. She experienced metallic taste following administration of FLUVIRIN. The patient was receiving immunosuppressant therapy after receiving a kidney transplant at unknown time. Medical history: Kidney transplant and metallic taste after transplantation. Agency reference no.: NA09-008414.
This case was reported by a nurse via call center representative and described the occurrence of pain in a adult patient who received Shingrix for prophylaxis. On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a year after receiving Shingrix, the patient experienced pain, malaise and injection site pain. On an unknown date, the outcome of the pain, malaise and injection site pain were unknown. It was unknown if the reporter considered the pain, malaise and injection site pain to be related to Shingrix. Additional details were provided as follows: The patient had reported experiencing malaise, feeling achy and that the vaccine was painful. Five out of 3 patients experienced the same events.
Sore arm after administration, resolved. moderna sore arm not exactly at injection site red, no fever. got a cold after 1st shot 5 days then sore again after another 5 days reported 2-18-21
Information has been received from a registered nurse (RN) concerning a female who was vaccinated PO with a dose of Rotateq (Lot# 656390/0239U). The RN reported that the patient subsequently gagged and coughed after the vaccine was administered. Unspecified medical attention was sought. Approximately 30 minutes after vaccination, the patient vomited blood. A guaiac test in the office was also positive for blood. No other symptoms or episodes of vomiting were reported. At the time of this report, the outcome was unknown. Upon internal review guaiac test positive for blood was determined to be an other important medical event. Additional information has been requested.
"MODERNA EUA requirement"     hospitalization due to hypotension, malaise, fever, acute renal failure,
At 8pm I felt very tired, all my body started hurting. At 10pm started feeling chills, low fever of 100.4, and headache, my body continued hurting and I had felt no energy to move. Fever went up to 101.9 during the night. Next day in the morning the fever and chills were gone, but the other symptoms persisted until 10pm. At that time all the symptoms were gone. The day of the vaccine I did not take any medicine, next day in the morning I took tylenol for the body ache and headache, but I did not help.
T/C received form mom, LL : redness and swelling, not in distress. Advised to use cool compresses.
2nd varicella vaccine given at 3 yrs (not recommended 4 yrs)
None/NA adverse events; administration error, given to early, received #1 dose 072706
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In NOVEMBER 2015, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In FEBRUARY 2016, the patient was treated by a physician at a medical group practice for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
had not yet gotten a period; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MENSTRUATION DELAYED (non-serious), outcome "unknown", described as "had not yet gotten a period". Additional information: The reporter was a transgender and stated that the patient got the covid 19 vaccine and had not gotten a period. The reporter was asking if that was the cause of the covid 19 shot that the patient got. The patient had not yet gotten a period and asked if the patient was pregnant.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient previously had 2 Moderna vaccinations. After each vaccination, patient had a bit of fever and didn't feel completely well. After her Moderna booster, patient had a fever, chills patient threw up 3 or 4 times, was unable to stand or walk, and had body aches. The next day, patient was not throwing up, but still had a fever, chills, and body aches. By the third day, these complaints were gone.
Bells Palsy; This is a spontaneous report from a contactable consumer. This consumer reported similar events for three patients. This is 1st of three reports.   A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (also reported as Comirnaty), via an unspecified route of administration on an unspecified in Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced bells palsy on Dec2020. The action taken in response to the event for bnt162b2 was not applicable. The outcome of event was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020519118 same reporter/drug/event, different patient;US-PFIZER INC-2020519119 same reporter/drug/event, different patient
Sick for 10 days after each time with hard core flu; Initial information received on 11-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer via social media.  This case involves patient (unknown demographics) who experienced sick for 10 days after each time with hard core flu (influenza), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick for 10 days after each time with hard core flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was also reported that had to take flu shot twice once in boot camp once for a job. Sick for 10 days after each time with hard core flu. No more flu shots for patient.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was reported as unknown.  There will be no information available on the batch number for this case.